Search Results

There are 11102 results for: content related to: The incorporation of the A2 protein to produce novel Qβ virus-like particles using cell-free protein synthesis

  1. Bioengineering virus-like particles as vaccines

    Biotechnology and Bioengineering

    Volume 111, Issue 3, March 2014, Pages: 425–440, Linda H.L. Lua, Natalie K. Connors, Frank Sainsbury, Yap P. Chuan, Nani Wibowo and Anton P.J. Middelberg

    Article first published online : 17 DEC 2013, DOI: 10.1002/bit.25159

  2. You have free access to this content
    Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion

    European Journal of Immunology

    Volume 41, Issue 11, November 2011, Pages: 3240–3252, Virginie M. Renoux, Bettina Bisig, Inge Langers, Estelle Dortu, Béatrice Clémenceau, Marc Thiry, Christophe Deroanne, Alain Colige, Jacques Boniver, Philippe Delvenne and Nathalie Jacobs

    Article first published online : 27 SEP 2011, DOI: 10.1002/eji.201141693

  3. Stabilization of human papillomavirus virus-like particles by non-ionic surfactants

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 7, July 2005, Pages: 1538–1551, Li Shi, Gautam Sanyal, Alex Ni, Zheng Luo, Sarah Doshna, Bei Wang, Tammy L. Graham, Ning Wang and David B. Volkin

    Article first published online : 31 MAY 2005, DOI: 10.1002/jps.20377

  4. You have free access to this content
    Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles

    FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1198–1208, Yang Pan, Yuan Zhang, Tingting Jia, Kuo Zhang, Jinming Li and Lunan Wang

    Article first published online : 23 FEB 2012, DOI: 10.1111/j.1742-4658.2012.08512.x

  5. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

    Volume 3, Issue 2, March/April 2011, Pages: 174–196, Emily M. Plummer and Marianne Manchester

    Article first published online : 24 SEP 2010, DOI: 10.1002/wnan.119

  6. Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 12, December 2011, Pages: 5156–5173, Lei Hu, Jared M. Trefethen, Yuhong Zeng, Luisa Yee, Satoshi Ohtake, David Lechuga-Ballesteros, Kelly L. Warfield, M. Javad Aman, Sergey Shulenin, Robert Unfer, Sven G. Enterlein, Vu Truong-Le, David B. Volkin, Sangeeta B. Joshi and C. Russell Middaugh

    Article first published online : 19 AUG 2011, DOI: 10.1002/jps.22724

  7. You have free access to this content
    The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza

    Plant Biotechnology Journal

    Volume 8, Issue 5, June 2010, Pages: 607–619, Marc-André D’Aoust, Manon M.-J. Couture, Nathalie Charland, Sonia Trépanier, Nathalie Landry, Frédéric Ors and Louis-P. Vézina

    Article first published online : 18 FEB 2010, DOI: 10.1111/j.1467-7652.2009.00496.x

  8. Newcastle Disease Virus-Like Particles: Preparation, Purification, Quantification, and Incorporation of Foreign Glycoproteins

    Unit

    Current Protocols in Microbiology

    18:18.2.1–18.2.21

    Lori W. McGinnes and Trudy G. Morrison

    Published Online : 2 OCT 2013, DOI: 10.1002/9780471729259.mc1802s30

  9. CD11c+ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice

    European Journal of Immunology

    Volume 44, Issue 2, February 2014, Pages: 397–408, Laura E. Richert, Agnieszka Rynda-Apple, Ann L. Harmsen, Soo Han, James A. Wiley, Trevor Douglas, Kyle Larson, Rachelle V. Morton and Allen G. Harmsen

    Article first published online : 13 JAN 2014, DOI: 10.1002/eji.201343587

  10. Molecular construction of bionanoparticles: chimaeric SIV p17–HIV I p6 nanoparticles with minimal viral protein content

    Biotechnology and Applied Biochemistry

    Volume 48, Issue 1, September 2007, Pages: 35–43, Maria J. L. Costa, Luísa Pedro, António P. Alves De Matos, Maria R. Aires-Barros, José A. Belo, João Goncalves and Guilherme N. M. Ferreira

    Article first published online : 23 DEC 2010, DOI: 10.1042/BA20060208

  11. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 10, October 2006, Pages: 2195–2206, Henryk Mach, David B. Volkin, Robert D. Troutman, Bei Wang, Zheng Luo, Kathrin U. Jansen and Li Shi

    Article first published online : 26 JUL 2006, DOI: 10.1002/jps.20696

  12. Development of a Stable Virus-Like Particle Vaccine Formulation against Chikungunya Virus and Investigation of the Effects of Polyanions

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 12, December 2013, Pages: 4305–4314, Ryan M. Kramer, Yuhong Zeng, Neha Sahni, Lisa A. Kueltzo, Richard M. Schwartz, Indresh K. Srivastava, Lindsey Crane, Sangeeta B. Joshi, David B. Volkin and C. Russell Middaugh

    Article first published online : 15 OCT 2013, DOI: 10.1002/jps.23749

  13. You have free access to this content
    Combined prophylactic and therapeutic cancer vaccine: Enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice

    International Journal of Cancer

    Volume 118, Issue 12, 15 June 2006, Pages: 3022–3029, Jiahua Qian, Yujun Dong, Yuk-Ying S. Pang, Ramy Ibrahim, Jay A. Berzofsky, John T. Schiller and Samir N. Khleif

    Article first published online : 19 JAN 2006, DOI: 10.1002/ijc.21781

  14. You have free access to this content
    Identification of an Intracellular Trafficking and Assembly Pathway for HIV-1 Gag

    Traffic

    Volume 7, Issue 6, June 2006, Pages: 731–745, Mira Perlman and Marilyn D. Resh

    Article first published online : 8 MAY 2006, DOI: 10.1111/j.1398-9219.2006.00428.x

  15. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer

    International Journal of Cancer

    Volume 134, Issue 7, 01 April 2014, Pages: 1683–1694, Jinming Li, Yanli Sun, Tingting Jia, Rui Zhang, Kuo Zhang and Lunan Wang

    Article first published online : 8 OCT 2013, DOI: 10.1002/ijc.28482

    Corrected by:

    Errata: Erratum: Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer

    Vol. 135, Issue 7, E5, Article first published online: 15 JUL 2014

  16. You have free access to this content
    Dynamic Imaging of Cell-Free and Cell-Associated Viral Capture in Mature Dendritic Cells

    Traffic

    Volume 12, Issue 12, December 2011, Pages: 1702–1713, Nuria Izquierdo-Useros, Olga Esteban, Maria T. Rodriguez-Plata, Itziar Erkizia, Julia G. Prado, Julià Blanco, Maria F. García-Parajo and Javier Martinez-Picado

    Article first published online : 10 OCT 2011, DOI: 10.1111/j.1600-0854.2011.01281.x

  17. You have free access to this content
    Virus-Like Particle-Based Countermeasures Against Rift Valley Fever Virus

    Zoonoses and Public Health

    Volume 59, Issue s2, September 2012, Pages: 142–150, R. Koukuntla, R. B. Mandell and R. Flick

    Article first published online : 7 SEP 2012, DOI: 10.1111/j.1863-2378.2012.01478.x

  18. Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 1, January 2006, Pages: 70–79, Roxana M. Ionescu, Craig T. Przysiecki, Xiaoping Liang, Victor M. Garsky, Jiang Fan, Bei Wang, Robert Troutman, Yvette Rippeon, Elizabeth Flanagan, John Shiver and Li Shi

    Article first published online : 28 NOV 2005, DOI: 10.1002/jps.20493

  19. You have free access to this content
    Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications

    Protein Science

    Volume 18, Issue 7, July 2009, Pages: 1425–1438, Maxime J. J. Fleury, Antoine Touzé, Marie-Christine Maurel, Thierry Moreau and Pierre Coursaget

    Article first published online : 20 MAY 2009, DOI: 10.1002/pro.156

  20. H1N1 influenza virus-like particles: Physical degradation pathways and identification of stabilizers

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 634–645, Julian Kissmann, Sangeeta B. Joshi, Joel R. Haynes, Leslie Dokken, Charles Richardson and C. Russell Middaugh

    Article first published online : 28 JUL 2010, DOI: 10.1002/jps.22304